O Doente com cateter pleural implantado (PleurX™): sete anos de experiência numa Unidade de Técnicas Endoscópicas de Pneumologia (UTEP)

Autores

  • Ana Catarina Vieira Almeida Instituto Português de Oncologia de Lisboa, Lisboa

Palavras-chave:

Derrame Pleural Maligno, Cateter Pleural Implantado, PleurX™

Resumo

Muitos doentes oncológicos, sobretudo com diagnósticos de cancro do pulmão e cancro da mama, têm Derrame Pleural Maligno. Existem diversas opções de tratamento, a maioria das quais requer hospitalização. O Cateter Pleural Implantado (CPI) PleurX™ (da BD, EUA) é um tratamento relativamente novo e realizado com doentes em ambulatório. Com o CPI, o derrame pleural pode ser drenado no domicílio pelo próprio doente ou seus familiares/outros cuidadores. Os enfermeiros detêm um papel crucial na educação do manuseio deste dispositivo à díade doente-família e a outros profissionais de saúde. O objectivo deste artigo consiste em caracterizar os doentes com PleurX de modo a identificar os cuidados de enfermagem adequados com intuito da excelência do cuidar e, ainda, dar a conhecer aos enfermeiros os cuidados a prestar aos doentes com CPI.

Downloads

Não há dados estatísticos.

Referências

Anderson CB, Philpott GW, Ferguson TB (1974). The treatment of malignant pleural effusions. Cancer. 33:916-922.

Antunes G, Neville E, J Duffy J, Ali N (2003). BTS guidelines for the management of malignant pleural effusions. Thorax. 58:ii29 –ii38.

Brims FJH, Davies HE, Lee YCG (2010). Respiratory chest pain: diagnosis and treatment. Med Clin North Am. 94(2):217–32.

Boshuizen RC, Thomas R, Lee YCG (2013). Advantages of indwelling pleural catheters for management of malignant pleural effusions. Curr Respir Care Rep. 2:93–99

Davies HE, Mishra EK, Kahan BC, Wrightson JM et al(2012). Effect of an indwelling pleural catheter vs chest tube and pleurodesis for relieving

dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 307 (22): 2383-2389.

Dresler CM, Olak J, Herndon JE, Richards WG et al (2005). Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 127(3):909-915.

Efthymiou CA, Masudi T, Thorpe JAC, Papagiannopoulos K (2009). Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 9(6):961-4.

Fysh ETH, Waterer GW, Kendall PA, Bremner PR et al (2012). Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant

pleural effusion. Chest. 142(2):394-400.

Haas AR, Sterman DH, Musani AI (2007). Malignant pleural effusions management options with consideration of coding, billing, and a decision

approach. Chest. 132:1036-1041.

Maskell, N. A. (2012). Treatment options for malignant pleural effusions: patient preference does matter. JAMA. 307(22):2432-2433.

Musani AI, Haas AR, Seijo L, Wilby M, Sterman DH (2004). Outpatient management of malignant pleural effusions with small-bore, tunneled

pleural catheters. Respiration. 71:559-66.

Neragi M. S. (2006). Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer. 54(1):1-9.

Pien GW, Gant MJ, Washam CL, Sterman DH (2001). Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest. 119:1641-6.

Puri V, TL Pyrdeck TL, Crabtree TD, Kreisel D et al (2012). Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg. 94:374–379.

Putnam Jr JB, Light RW, Rodriguez RM, Ponn R et al (1999). A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86 (10):1992—1999.

Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ (2010). BTS Pleural

Disease Guideline Group: Management of a malignant pleural effusion.

British Thoracic Society Pleural Disease Guideline 2010. Thorax. 65:(suppl

ii32-ii40.

Sioris T, Sihvo E, Salo J, Räsänen J, Knuuttila A (2009). Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. Eur J Surg Oncol. 35(5):546–51.

Tremblay A, Mason C, Michaud G. (2007). Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J.

:759-62.

Tremblay A, Michaud G. (2006) Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest.129:362-8.

Van den Toorn LM, Schaap E, Surmont VFM, Pouw EM et al (2005). Management of recurrent malignant pleural effusions with a chronic

indwelling pleural catheter. Lung Cancer. 50:123-7.

Van Meter M, McKee K, Kohlwes R. (2010) Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 26:70 –76.

Downloads

Publicado

15-06-2019

Como Citar

1.
Catarina Vieira Almeida A. O Doente com cateter pleural implantado (PleurX™): sete anos de experiência numa Unidade de Técnicas Endoscópicas de Pneumologia (UTEP). journal [Internet]. 15 de Junho de 2019 [citado 28 de Maio de 2024];(38):16-23. Disponível em: https://onco.news/index.php/journal/article/view/46

Edição

Secção

Artigos de Revisão